Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
about
Fluoxetine versus other types of pharmacotherapy for depressionEfficacy of levomilnacipran extended-release in improving functional impairment associated with major depressive disorder: pooled analyses of five double-blind, placebo-controlled trialsLevomilnacipran Extended-Release Treatment in Patients With Major Depressive Disorder: Improvements in Functional Impairment Categories.Early Improvement in Psychosocial Function Predicts Longer-Term Symptomatic Remission in Depressed Patients.Functioning in patients with major depression treated with duloxetine or a selective serotonin reuptake inhibitor in East AsiaLongitudinal social-interpersonal functioning among higher-risk responders to acute-phase cognitive therapy for recurrent major depressive disorder.Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 Clinical Guidelines for the Management of Adults with Major Depressive Disorder: Section 3. Pharmacological TreatmentsDaily activity level improvement with antidepressant medications predicts long-term clinical outcomes in outpatients with major depressive disorder.A meta-analysis of the efficacy of venlafaxine extended release 75-225 mg/day for the treatment of major depressive disorder.Clinical outcomes of patients with major depressive disorder treated with either duloxetine, escitalopram, fluoxetine, paroxetine, or sertralineSafety and effectiveness of escitalopram in an 8-week open study in Chinese patients with depression and anxiety
P2860
Q24201165-C3FF2782-621C-440E-B5DD-5D938C6D66D4Q33718213-87376E58-8B10-4331-8F3E-B15942969883Q36083249-AF756C19-88F0-4907-A3F4-57AB1AC7FC29Q36234571-2832B2D9-FF64-4B7A-9E95-9F00AB619804Q36627458-9E8801E6-0CFC-4F51-B6DD-3D60504BCD98Q36889128-6071AE08-BACC-4DEE-9A86-31132095E4F9Q37197216-9991283C-C08D-4C56-8EEF-994E4BFB8879Q37712388-66CFD9B9-D96F-4676-8AC9-C8923FF4214DQ48037730-191858E3-EA9C-43B1-A053-B6F07BB97F9FQ57491808-83B5D24F-E99E-4559-8D56-3122BEC0E24EQ58781967-ADE852A1-5EB4-4A9D-9977-9540349FE572
P2860
Psychosocial outcomes in patients with recurrent major depressive disorder during 2 years of maintenance treatment with venlafaxine extended release.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Psychosocial outcomes in patie ...... venlafaxine extended release.
@en
type
label
Psychosocial outcomes in patie ...... venlafaxine extended release.
@en
prefLabel
Psychosocial outcomes in patie ...... venlafaxine extended release.
@en
P2093
P2860
P1476
Psychosocial outcomes in patie ...... venlafaxine extended release.
@en
P2093
Alan Gelenberg
Anthony J Rothschild
David L Dunner
Edward S Friedman
James H Kocsis
John M Zajecka
Madhukar H Trivedi
Martin B Keller
Michael E Thase
Richard C Shelton
P2860
P304
P356
10.1016/J.JAD.2010.04.011
P577
2010-05-26T00:00:00Z